Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Always Active
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

Bernard
Pécoul

28 August 2019

Dr Bernard Pécoul led the Drugs for Neglected Diseases initiative (DNDi) from its foundation in 2003 until 2022. Under his leadership, DNDi – a not-for-profit research and development organization – expanded to include hundreds of public and private partners on five continents. During his tenure, DNDi delivered 12 new treatments for six deadly diseases, including malaria, leishmaniasis, sleeping sickness and Chagas disease. Dr Pécoul’s work has helped to demonstrate that an alternative, collaborative model of research & development can deliver to meet the needs of neglected patients. During his time at DNDi, the organization established five research platforms that are driving scientific and medical progress in countries and communities most affected by neglected diseases. Dr Pécoul is a lifelong advocate for better access to medicines.

In 2016, DNDi, together with the World Health Organization, created GARDP to address the growing threat of antimicrobial resistance. GARDP became an independent entity in 2018.

Dr Pécoul is a recipient of the Prince Mahidol Award in the field of public health (2020) and the American Society of Tropical Medicine and Hygiene Clara Southmayd Ludlow Medal (2022).

He began his career as a Médecins Sans Frontières (MSF) doctor in 1983, working in Africa, Latin America and Asia. He later served as Executive Director of MSF France from 1991 to 1998 and as Director of the MSF Access to Essential Medicines Campaign from 1998 to 2003. In 1988, he co-founded Epicentre, an MSF-affiliated NGO specializing in epidemiology. After obtaining his medical degree at the University of Clermont-Ferrand, France, Dr Pécoul earned a master’s degree in public health at Tulane University, USA. In 2012, he was awarded an honorary Doctor of Laws degree by the University of Dundee, UK. Dr Pécoul was a board member of GARDP from 2019 to 2024. He is a member of the Board of the European Clinical Research Alliance on Infectious Diseases (ECRAID) and a former founding board member of UNITAID’s Medicines Patent Pool.